Flu and COVID-19 vaccination programme - autumn/winter 2021-2022: equality impact assessment

An equality impact assessment (EQIA) for the autumn/winter 2021-2022 Flu and COVID-19 vaccination programme.

What might prevent the desired outcomes being achieved?

87. Achieving the desired short and long term aims of the policy is dependent on the effectiveness of the COVID-19 vaccines that are produced and distributed to the people of Scotland. There are multiple dependencies which may prevent such an outcome. These are, but not limited to:

  • vaccine efficacy and/or immunogenicity in different age and risk groups;
  • the safety of administration in different age and risk groups;
  • the effect of the vaccine on acquisition of infection and transmission;
  • the transmission dynamics of the SARS-CoV-2 virus in the UK population;
  • the epidemiological, microbiological, and clinical characteristics of COVID-19, in particular, emerging variants and the effect of the vaccine on these variants and any vaccine escape;
  • secure supply of effective vaccines, including the impact of challenges with development, manufacture and logistics which may be affected by geopolitical issues;
  • the storage, transportation and pack down of available COVID-19 vaccines
  • the lack of single dose COVID-19 vials which would facilitate opportunistic vaccination for example in primary care and community pharmacy settings; and
  • inequitable access to and uptake of the vaccine across the Scottish population.


Email: Vacsbusinesssupport@gov.scot

Back to top